News | Conquer Cancer, the ASCO Foundation

Alexandria, Va. - Conquer Cancer®, the ASCO Foundation, welcomes Kathryn Beal, MD, to its Board of Directors. Dr. Beal will help guide Conquer Cancer in its support of funding breakthrough research for every type of cancer. 

“We are pleased to welcome Dr. Beal to the Board and grateful for her willingness to volunteer her time and resources to advance our mission to accelerate lifesaving research and empower people everywhere to conquer cancer,” said Chief Executive Officer Nancy R. Daly, MS, MPH. 

To support people and communities affected by cancer amidst the crisis in Ukraine, Conquer Cancer®, the ASCO Foundation, is helping fund emergency resources. Learn more here.

Cancer.Net, supported in part by Conquer Cancer donors, and Cancer.org to Cross-Share Select Patient and Consumer Resources

Alexandria, Va. and Atlanta, Ga. – The American Society of Clinical Oncology (ASCO) and the American Cancer Society (ACS) today initiated a collaboration to ensure that people can easily find the trusted, expert-approved cancer content they need when turning to either organization for information.

ALEXANDRIA, Va. – Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2022 Genitourinary Cancers Symposium Merit Awards.   

These distinguished awards recognize oncology fellows and trainees who are first authors on top-ranking abstracts selected for presentation at the ASCO Genitourinary Cancers Symposium on February 17- 19, 2022.    

These 30 oncology professionals are recognized for their respective field and research advancements within the cancer care community:    

ALEXANDRIA, Va. – Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2022 Gastrointestinal Cancers Symposium Merit Awards.   

These distinguished awards recognize oncology fellows and trainees who are first authors on top-ranking abstracts selected for presentation at the Gastrointestinal Cancers Symposium on January 20 – 22, 2022.  

These 30 oncology professionals are recognized for their respective field and research advancements within the cancer care community:    

A few years ago, we introduced you to Bella Raffin. We are thrilled to share this inspiring update.  

Bella was only 8 when she was diagnosed with Stage IV neuroblastoma, a solid cancerous tumor that begins most often in the nerve cells outside the brain of infants and children younger than 5.